A comprehensive epidemiological investigation led by researchers from Harvard Medical School has identified a significant link between residential proximity to industrial water polluters and the development of progressive supranuclear palsy (PSP). Published in the journal Neurology on October 28, 2026, the study analyzed data from more than 500,000 adults in the United Kingdom over a 25-year period. The findings indicate that individuals residing within three miles of facilities releasing specific pollutants face an elevated likelihood of developing this rare and rapid neurodegenerative movement disorder.
The research team, led by Dr. Charlie Weige Zhao of Harvard Medical School and Massachusetts General Hospital, tracked environmental exposures by matching 221 individuals with clinically confirmed PSP against 10 healthy control participants for each case. By geocoding baseline residential addresses from 2007, the investigators assessed proximity to regulated industrial sites such as wastewater treatment centers, chemical plants, and thermal power stations. The analysis focused on six classes of pollutants, including heavy metals, agricultural pesticides, and various organic and inorganic compounds.
The study revealed distinct risk profiles based on the type of pollutant emitted by nearby facilities. Residents living within three miles of sites discharging agricultural pesticides, such as atrazine, simazine, and diuron, demonstrated a 66% increased risk of developing PSP compared to those living farther away. Similarly, proximity to facilities emitting inorganic pollutants like fluorides and phosphorus was associated with a 60% higher risk, while exposure to organic compounds including benzene and toluene correlated with a 52% increase. Facilities releasing heavy metals such as lead, cadmium, and mercury were linked to a 38% elevated risk.
A notable distance-decay effect was observed, where the risk of PSP steadily attenuated as the geographical distance from industrial sites increased, with associations tapering off beyond approximately six miles. Furthermore, the cumulative duration of residence near these polluting facilities also correlated with disease risk. Approximately one-third of individuals who developed PSP lived within three miles of an industrial facility, compared to roughly one-quarter of the control group. No statistically significant associations were found for chlorinated solvents or persistent organic pollutants.
Dr. Zhao noted that while PSP is an exceedingly rare condition affecting roughly 5 to 6 individuals per 100,000 people, these results suggest environmental water pollutants may play a role in its development. The study authors emphasized that the design establishes a statistical association rather than direct biological causation. Limitations include the lack of detailed occupational histories and the difficulty of isolating the toxicological contribution of individual chemicals within complex industrial mixtures. The findings support further toxicological research into how industrial chemicals may penetrate the blood-brain barrier to trigger tauopathy, while highlighting the importance of clean water infrastructure and environmental regulation.
Sources: Neuroscience News.